Ad is loading...
GCCSX
Price
$34.49
Change
+$0.42 (+1.23%)
Updated
Nov 22 closing price
VSMAX
Price
$123.45
Change
+$1.87 (+1.54%)
Updated
Nov 22 closing price
Ad is loading...

GCCSX vs VSMAX

Header iconGCCSX vs VSMAX Comparison
Open Charts GCCSX vs VSMAXBanner chart's image
Gabelli Small Cap Growth C
Price$34.49
Change+$0.42 (+1.23%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index
Price$123.45
Change+$1.87 (+1.54%)
VolumeN/A
CapitalizationN/A
GCCSX vs VSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCCSX vs. VSMAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCCSX is a Buy and VSMAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 151B vs. GCCSX (1.89B). VSMAX pays higher dividends than GCCSX: VSMAX (1.42) vs GCCSX (0.16). GCCSX was incepted earlier than VSMAX: GCCSX (21 years) vs VSMAX (24 years). VSMAX is a more actively managed with annual turnover of: 12.00 vs. GCCSX (1.00). GCCSX has a lower initial minimum investment than VSMAX: GCCSX (1000) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 34.52 vs. GCCSX (21.46). VSMAX return over 5 years is better than : 63.57 vs. GCCSX (-10.02).
GCCSXVSMAXGCCSX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD9.83221.10047%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.89B151B1%
Annual Yield % from dividends0.161.4211%
Returns for 1 year21.4634.5262%
Returns for 3 years-19.0912.56-152%
Returns for 5 years-10.0263.57-16%
Returns for 10 years-23.58130.29-18%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOPE166.454.32
+2.66%
Grand Canyon Education
MPWR580.818.34
+1.46%
Monolithic Power Systems
CIM14.660.04
+0.27%
Chimera Investment Corp
INKT0.68-0.01
-1.46%
MiNK Therapeutics
ME3.11-0.12
-3.72%
23andMe Holding Co